secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevance Health, Inc. (ELV)
CIK:        0001156039
Form:       8-K
Filed at:   2026-04-22T23:59:59+00:00
Accession:  0001156039-26-000039
Event type: earnings
Sentiment:  positive
Materiality: 0.78
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elevance Health Q1 adj EPS $12.58 beats; raises FY2026 adj EPS guidance to at least $26.75
--------------------------------------------------------------------------------

- Q1 operating revenue $49.5B (+1.5% YoY); diluted EPS $8.00, adjusted diluted EPS $12.58 (includes ~$1 non-recurring investment income).
- Health Benefits segment revenue $42.5B (+2.6% YoY); operating margin 5.1% vs 5.4% YoY.
- Carelon segment revenue $18.0B (+7.9% YoY); operating margin 5.9% vs 6.6% YoY.
- Recorded $935M accrual for CMS matter and $129M business optimization charge; adjusted operating margin 6.5%.
- FY2026 adjusted EPS guidance raised to at least $26.75; reaffirm operating cash flow at least $5.5B.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1156039/000115603926000039/0001156039-26-000039-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1156039/000115603926000039/elv-20260422.htm
  HTML page:      https://secwatch.observer/filing/0001156039-26-000039

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer